Amgen Revenue Boosted By COVID-19 Manufacturing, Flat To Down Without It

Performance Highlights Need For Near-Term Growth Drivers

 
• By Mandy Jackson
  
Amgen sign in Silicon Valley, 21 September 2020
Amgen's product sales declined 1% in Q4 and were flat for the full year • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business